204 related articles for article (PubMed ID: 20037791)
1. Genes involved with folate uptake and distribution and their association with colorectal cancer risk.
Figueiredo JC; Levine AJ; Lee WH; Conti DV; Poynter JN; Campbell PT; Duggan D; Lewinger JP; Martinez ME; Ulrich CM; Newcomb P; Potter J; Limburg PJ; Hopper J; Jenkins MA; Le Marchand L; Baron JA; Haile RW
Cancer Causes Control; 2010 Apr; 21(4):597-608. PubMed ID: 20037791
[TBL] [Abstract][Full Text] [Related]
2. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients.
Odin E; Wettergren Y; Nilsson S; Willén R; Carlsson G; Spears CP; Larsson L; Gustavsson B
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6012-9. PubMed ID: 14676127
[TBL] [Abstract][Full Text] [Related]
3. A candidate gene study of folate-associated one carbon metabolism genes and colorectal cancer risk.
Levine AJ; Figueiredo JC; Lee W; Conti DV; Kennedy K; Duggan DJ; Poynter JN; Campbell PT; Newcomb P; Martinez ME; Hopper JL; Le Marchand L; Baron JA; Limburg PJ; Ulrich CM; Haile RW
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1812-21. PubMed ID: 20615890
[TBL] [Abstract][Full Text] [Related]
4. Alcohol-associated folate disturbances result in altered methylation of folate-regulating genes.
Wani NA; Hamid A; Kaur J
Mol Cell Biochem; 2012 Apr; 363(1-2):157-66. PubMed ID: 22147198
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population.
Hashiguchi M; Tanaka T; Shimizu M; Tsuru T; Chiyoda T; Miyawaki K; Irie S; Takeuchi O; Hakamata J; Mochizuki M
J Clin Pharmacol; 2016 Dec; 56(12):1563-1569. PubMed ID: 27146084
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of folate levels after leucovorin administration in colorectal cancer.
Sadahiro S; Suzuki T; Maeda Y; Tanaka A; Ogoshi K; Kamijo A; Murayama C; Tsukioka S; Sakamoto E; Fukui Y; Oka T
Cancer Chemother Pharmacol; 2010 Mar; 65(4):735-42. PubMed ID: 19636555
[TBL] [Abstract][Full Text] [Related]
7. Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study.
Levine AJ; Lee W; Figueiredo JC; Conti DV; Vandenberg DJ; Davis BD; Edlund CK; Henning SM; Heber D; Stern MC; Haile RW
Cancer Causes Control; 2011 Apr; 22(4):541-52. PubMed ID: 21274745
[TBL] [Abstract][Full Text] [Related]
8. Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients.
Sandhu A; Ahmad S; Kaur J; Bhatnagar A; Dhawan V; Dhir V
Clin Rheumatol; 2018 Dec; 37(12):3221-3228. PubMed ID: 30022368
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in folylpolyglutamate synthase and gamma-glutamyl hydrolase and plasma homocysteine levels in the Singapore Chinese Health Study.
Oppeneer SJ; Ross JA; Koh WP; Yuan JM; Robien K
Mol Genet Metab; 2012 Jan; 105(1):73-8. PubMed ID: 22018726
[TBL] [Abstract][Full Text] [Related]
10. The folate hydrolase 1561C>T polymorphism is associated with depressive symptoms in Puerto Rican adults.
Ye X; Lai CQ; Crott JW; Troen AM; Ordovas JM; Tucker KL
Psychosom Med; 2011 Jun; 73(5):385-92. PubMed ID: 21597034
[TBL] [Abstract][Full Text] [Related]
11. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
[TBL] [Abstract][Full Text] [Related]
12. Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.
Dervieux T; Kremer J; Lein DO; Capps R; Barham R; Meyer G; Smith K; Caldwell J; Furst DE
Pharmacogenetics; 2004 Nov; 14(11):733-9. PubMed ID: 15564880
[TBL] [Abstract][Full Text] [Related]
13. Mutations in folate transporter genes and risk for human myelomeningocele.
Findley TO; Tenpenny JC; O'Byrne MR; Morrison AC; Hixson JE; Northrup H; Au KS
Am J Med Genet A; 2017 Nov; 173(11):2973-2984. PubMed ID: 28948692
[TBL] [Abstract][Full Text] [Related]
14. The reduced folate carrier (RFC1) 80G > A and folate hydrolase 1 (FOLH1) 1561C > T polymorphisms and the risk of colorectal cancer: a nested case-referent study.
Eklöf V; Van Guelpen B; Hultdin J; Johansson I; Hallmans G; Palmqvist R
Scand J Clin Lab Invest; 2008; 68(5):393-401. PubMed ID: 19172696
[TBL] [Abstract][Full Text] [Related]
15. Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.
Yamamoto T; Shikano K; Nanki T; Kawai S
Sci Rep; 2016 Oct; 6():35615. PubMed ID: 27752107
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer.
Ulrich CM; Curtin K; Potter JD; Bigler J; Caan B; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2509-16. PubMed ID: 16284371
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry.
Levine AJ; Figueiredo JC; Lee W; Poynter JN; Conti D; Duggan DJ; Campbell PT; Newcomb P; Martinez ME; Hopper JL; Le Marchand L; Baron JA; Limburg PJ; Ulrich CM; Haile RW
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):89-100. PubMed ID: 20056627
[TBL] [Abstract][Full Text] [Related]
18. Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele.
O'Byrne MR; Au KS; Morrison AC; Lin JI; Fletcher JM; Ostermaier KK; Tyerman GH; Doebel S; Northrup H
Birth Defects Res A Clin Mol Teratol; 2010 Aug; 88(8):689-94. PubMed ID: 20683905
[TBL] [Abstract][Full Text] [Related]
19. Association of dietary and supplemental folate intake and polymorphisms in three FOCM pathway genes with colorectal cancer in a population-based case-control study.
Ashmore JH; Lesko SM; Muscat JE; Gallagher CJ; Berg AS; Miller PE; Hartman TJ; Lazarus P
Genes Chromosomes Cancer; 2013 Oct; 52(10):945-53. PubMed ID: 23893618
[TBL] [Abstract][Full Text] [Related]
20. Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
Smit EF; Socinski MA; Mullaney BP; Myrand SP; Scagliotti GV; Lorigan P; Reck M; Ciuleanu T; von Pawel J; Karaseva NA; Szczesna A; Ohannesian D; Powell E; Hozak RR; Hong S; Guba SC; Thatcher N
Ann Oncol; 2012 Jul; 23(7):1723-9. PubMed ID: 22186609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
